Streetbeat News

Stock Prices

EIS

ISRA

The Israeli military has announced that its operations in Lebanon will continue tonight. This development may have implications for regional stability and could impact related ETFs.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 12:19 pm

EWJ

Japan's new Prime Minister, Ishiba, has announced that his administration will prioritize a complete exit from deflation. This policy focus could have implications for Japanese equities and related ETFs.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 12:16 pm

SLXN

Silexion Therapeutics shares rose following the announcement of new preclinical findings for their drug candidate SIL-204.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 12:14 pm

STTK

Shattuck Labs shares fell after announcing the discontinuation of its SL-172154 clinical program due to modest results. The company will focus on developing SL-325 for inflammatory bowel disease, with an IND filing expected in Q3 2025. Restructuring is expected to extend cash runway into 2027.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 12:13 pm

OCEA

Ocean Biomedical has published new research on their novel cancer immunotherapy targeting CHI3L1, which shows promise in treating various cancers and COPD by inhibiting immune responses. The research highlights the potential of CHI3L1-targeted therapeutics in oncology.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 12:11 pm

ALUR

Allurion has published a meta-analysis demonstrating an average weight loss of 12.5% and significant metabolic health benefits across 2,107 patients in 11 studies. This could positively impact Allurion's market position and investor sentiment.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 12:11 pm

CI

CVS

UNH

CVS Health is considering restructuring by potentially splitting its retail and insurance divisions to address financial challenges. The company faces investor pressure and a valuation gap compared to competitors like UnitedHealth and Cigna. Discussions include possibly unwinding the $70 billion Aetna acquisition. CVS Health's stock rose 2.21% in premarket trading.

Portfolio Pulse from Vandana Singh

October 01, 2024 | 12:10 pm

INAB

IN8bio is conducting a private placement to sell 25.8 million shares, 5.6 million pre-funded warrants, and 31.4 million Series C warrants at $0.395 per unit.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 12:08 pm

AMBO

BODI

CULP

QRTEP

TOUR

ZCMD

In Tuesday's pre-market session, several consumer discretionary stocks experienced significant price movements. Beachbody Co (BODI) saw an 18% increase, while ZHONGCHAO (ZCMD) declined by 11%. Other notable gainers include Tuniu (TOUR) and Culp (CULP), while Qurate Retail (QRTEP) and Ambow Education Holding (AMBO) were among the losers.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 12:07 pm

ADGM

APDN

CHRO

IGMS

SLXN

STTK

The article highlights the pre-market movements of various healthcare stocks on Tuesday. Notable gainers include Silexion Therapeutics, Adagio Medical Holdings, and Chromocell Therapeutics, while significant losers include Shattuck Labs, IGM Biosciences, and Applied DNA Sciences.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 12:07 pm